Methylene Chloride

Methylene Chloride

SCHEMBL58857

COC(C)(C)C.ClCCl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylene Chloride SCHEMBL3607910 0.93 ALDH1A1 (0.57)
Chloromethane SCHEMBL774036 0.87
Alcohol SCHEMBL28968938 0.87 ALDH1A1 (0.50)
Hexane SCHEMBL9152574 0.84 ALDH1A1 (0.47)
Heptane SCHEMBL8040709 0.82 TSHR (0.48)
SCHEMBL503396 0.82
SCHEMBL6223 0.82
SCHEMBL8679785 0.82 ALDH1A1 (1.00)
Methylene Chloride SCHEMBL1249920 0.80 ALDH1A1 (0.40)
SCHEMBL3664027 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 624 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114258394-B Crystal form of oncogenic fusion kinase inhibitor and application thereof 南京再明医药有限公司 2024-04-23 CN claimed
CN-115397426-B Ebutinib glucolactone co-crystal and preparation method thereof 天津睿创康泰生物技术有限公司 2024-02-09 CN claimed
US-20240043430-A1 CRYSTAL FORM OF CASEIN KINASE 1e INHIBITOR AND PREPARATION METHOD AND USE THEREOF Hangzhou Healzen Therapeutics Co., Ltd. (CN) 2024-02-08 US claimed
EP-4269412-A1 CRYSTAL FORM OF CASEIN KINASE 1E INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Hangzhou Healzen Therapeutics Co., Ltd. (CN) 2023-11-01 EP claimed
CN-111868049-B Process for preparing somatostatin modulators 克林提克斯医药股份有限公司 2023-06-30 CN claimed
CN-115397426-A Ibutotinib glucolactone eutectic and preparation method thereof 天津睿创康泰生物技术有限公司 2022-11-25 CN claimed
EP-4023648-A1 CRYSTAL OF CARCINOGENIC FUSED KINASE INHIBITOR AND APPLICATIONS THEREOF Simcere Pharmaceutical Co. Ltd. (CN) 2022-07-06 EP claimed
CN-114685566-A Benzene arsenic oxide crystal form I, crystal form II and crystal form III and preparation method thereof 江苏挪贝肽医药科技有限公司 2022-07-01 CN claimed
CN-114656468-A Crystal form of casein kinase 1 epsilon inhibitor, preparation method and application thereof 杭州和正医药有限公司 2022-06-24 CN claimed
CN-114258394-A Crystal form of oncogenic fusion kinase inhibitor and application thereof 先声药业有限公司 2022-03-29 CN claimed
US-20210087165-A1 PROCESS OF MAKING SOMATOSTATIN MODULATORS Crinetics Pharmaceuticals, Inc. 2021-03-25 US claimed
WO-2021037156-A1 CRYSTAL OF CARCINOGENIC FUSED KINASE INHIBITOR AND APPLICATIONS THEREOF 南京明德新药研发有限公司 2021-03-04 WO claimed
EP-3740475-A1 PROCESS OF MAKING SOMATOSTATIN MODULATORS Crinetics Pharmaceuticals, Inc. (US) 2020-11-25 EP claimed
CN-111868049-A Methods of making somatostatin modulators 克林提克斯医药股份有限公司 2020-10-30 CN claimed
US-20200048219-A1 PROCESS OF MAKING SOMATOSTATIN MODULATORS Crinetics Pharmaceuticals, Inc. 2020-02-13 US claimed
WO-2019143718-A1 PROCESS OF MAKING SOMATOSTATIN MODULATORS Crinetics Pharmaceuticals, Inc. (US) 2019-07-25 WO claimed
US-8809526-B2 Synthesis of cyclopentaquinazolines ONYX PHARMACEUTICALS, INC. (US) 2014-08-19 US claimed
US-20130211082-A1 Synthesis of Cyclopentaquinazolines ONYX PHARMACEUTICALS, INC. (US) 2013-08-15 US claimed
US-8314145-B2 High purity 17α-cyanomethyl-17β-hydroxy-estra-4,9-diene-3-one and process for the synthesis thereof RICHTER GEDEON VEGYESZETI GYAR RT (HU) 2012-11-20 US claimed
EP-1963354-B1 HIGH PURITY 17alfa-CYANOMETHYL-17beta-HYDROXY-ESTRA-4,9-DIENE-3-ONE AND PROCESS FOR THE SYNTHESIS THEREOF RICHTER GEDEON NYRT (HU) 2009-12-09 EP claimed